Advertisement

Intramuscular Followed by Oral Vitamin A Supplementation in Neonates with Birth Weight from 750 to 1250 g: A Randomized Controlled Trial

  • S. Giridhar
  • Jogender Kumar
  • Savita Verma Attri
  • Sourabh Dutta
  • Praveen KumarEmail author
Original Research Article
  • 20 Downloads

Abstract

Multiple intramuscular (IM) injections of vitamin A have been shown to decrease bronchopulmonary dysplasia in very low birth weight (VLBW) neonates. However, this regime is neither practical nor popular. Oral vitamin A has failed to achieve adequate plasma levels. We aimed to investigate if a schedule of initial IM followed by oral supplementation can reduce vitamin A deficiency. This was a blinded, randomized controlled trial, conducted in a level III neonatal unit. Neonates with birth weight from 750 to 1250 g, were enrolled at the age of 24–96 h of life. They were randomly allocated to vitamin A supplementation (VAS) (n = 61) or placebo group (n = 59). VAS group received vitamin A 5000 IU IM on alternate days till establishment of adequate enteral feeds, followed by oral 10,000 IU daily for 28 days. The primary outcome was incidence of vitamin A deficiency (plasma retinol < 200 μg/L) on day 28. A total of 120 neonates with mean (SD) gestation age and birth weight of 31 (2.4) weeks and 1065 (141) g, respectively were enrolled. More than 90% of cases were vitamin A deficient at the baseline. The proportion of vitamin A deficient infants on day 28 of study was significantly lower in VAS group compared to placebo group (4% vs. 61%, p < 0.001). The median (1st–3rd quartile) plasma retinol levels (μg/L) were significantly higher in VAS group compared to placebo [489 (295,627) vs. 184 (156,240), p < 0.001]. We conclude that the IM followed by oral VAS significantly reduced the incidence of vitamin A deficiency in VLBW infants.

Keywords

Bronchopulmonary dysplasia Neonate Very low birth weight Vitamin A 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedure performed in study were in accordance with the ethical standards of the Institutional Ethics Committee of PGIMER Chandigarh and with the 1964 Helsinki declaration and its later amendments.

References

  1. 1.
    Wardle SP, Hughes A, Chen S, Shaw NJ. Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Arch Dis Child Fetal Neonatal Ed. 2001;84:F9–13.CrossRefGoogle Scholar
  2. 2.
    Darlow BA, Graham PJ, Rojas-Reyes MX. Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants. Cochrane Database Syst Rev. 2016.  https://doi.org/10.1002/14651858.CD000501.pub4 CrossRefPubMedGoogle Scholar
  3. 3.
    Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med. 1999;340:1962–8.CrossRefGoogle Scholar
  4. 4.
    Ambalavanan N, Wu T-J, Tyson JE, Kennedy KA, Roane C, Carlo WA. A comparison of three vitamin a dosing regimens in extremely-low-birth-weight infants. J Pediatr. 2003;142:656–61.CrossRefGoogle Scholar
  5. 5.
    Gawronski CA, Gawronski KM. Vitamin A supplementation for prevention of bronchopulmonary dysplasia: cornerstone of care or futile therapy? Ann Pharmacother. 2016;50:680–4.CrossRefGoogle Scholar
  6. 6.
    Baveja R, Christou H. Pharmacological strategies in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:209–18.CrossRefGoogle Scholar
  7. 7.
    Ambalavanan N, Carlo WA. Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:192–9.CrossRefGoogle Scholar
  8. 8.
    Shenai JP, Kennedy KA, Chytil F, Stahlman MT. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr. 1987;111:269–77.CrossRefGoogle Scholar
  9. 9.
    Pearson E, Bose C, Snidow T, et al. Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. J Pediatr. 1992;121:420–7.CrossRefGoogle Scholar
  10. 10.
    Ambalavanan N, Kennedy K, Tyson J, Carlo WA. Survey of vitamin a supplementation for extremely-low-birth-weight infants: is clinical practice consistent with the evidence? J Pediatr. 2004;145:304–7.CrossRefGoogle Scholar
  11. 11.
    Shenai JP. Vitamin A supplementation in very low birth weight neonates: rationale and evidence. Pediatrics. 1999;104:1369–74.CrossRefGoogle Scholar
  12. 12.
    Walsh MC. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004;114:1305–11.CrossRefGoogle Scholar
  13. 13.
    Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–9.CrossRefGoogle Scholar
  14. 14.
    Gastmeier P, Geffers C, Schwab F, Fitzner J, Obladen M, Ruden H. Development of a surveillance system for nosocomial infections: the component for neonatal intensive care units in Germany. J Hosp Infect. 2004;57:126–31.CrossRefGoogle Scholar
  15. 15.
    Ravishankar C, Nafday S, Green RS, et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants. J Pediatr. 2003;143:644–8.CrossRefGoogle Scholar
  16. 16.
    Coutsoudis A, Adhikari M, Coovadia HM. Serum vitamin A (retinol) concentrations and association with respiratory disease in premature infants. J Trop Pediatr. 1995;41:230–3.CrossRefGoogle Scholar
  17. 17.
    Charafeddine L, D’Angio CT, Phelps DL. Atypical chronic lung disease patterns in neonates. Pediatrics. 1999;103:759–65.CrossRefGoogle Scholar
  18. 18.
    Coutsoudis A, Adhikari M, Pillay K, Kuhn L, Coovadia HM. Effect of vitamin A supplementation on morbidity of low-birth-weight neonates. S Afr Med J. 2000;90:730–6.PubMedGoogle Scholar
  19. 19.
    Meyer S, Gortner L. Early postnatal additional high-dose oral vitamin a supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants. Neonatology. 2014;105:182–8.CrossRefGoogle Scholar
  20. 20.
    Rakshasbhuvankar A, Patole S, Simmer K, Pillow JJ. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial. BMC Pediatr. 2017;17:204.CrossRefGoogle Scholar
  21. 21.
    Calisici E, Yarci E, Degirmencioglu H, et al. PO-0731 the effects of early oral vitamin A treatment on the prevention of bronchopulmonary displasia in the low birth weight Infants. Arch Dis Child. 2014;99(Suppl 2):A494.Google Scholar
  22. 22.
    Meyer S, Gortner L, NeoVitaA Trial investigators. Up-date on the NeoVitaA Trial: obstacles, challenges, perspectives, and local experiences. Wien Med Wochenschr. 2017;167:264–70.CrossRefGoogle Scholar
  23. 23.
    Brandt RB, Mueller DG, Schroeder JR, et al. Serum vitamin A in premature and term neonates. J Pediatr. 1978;92:101–4.CrossRefGoogle Scholar
  24. 24.
    Tolba AM, Hewedy FM, Al-Senaidy AM, Al-Othman AA. Neonates’ vitamin A status in relation to birth weight, gestational age, and sex. J Trop Pediatr. 1998;44:174–7.CrossRefGoogle Scholar
  25. 25.
    Mazumder S, Taneja S, Bhatia K, Neovita India Study Group, et al. Efficacy of early neonatal supplementation with vitamin A to reduce mortality in infancy in Haryana, India (Neovita): a randomised, double-blind, placebo-controlled trial. Lancet. 2015;385:1333–42.CrossRefGoogle Scholar
  26. 26.
    Shah RS, Rajalakshmi R. Vitamin A status of the newborn in relation to gestational age, body weight, and maternal nutritional status. Am J Clin Nutr. 1984;40:794–800.CrossRefGoogle Scholar
  27. 27.
    Mishra S, Thomas K, Agarwal R, Gupta YK, Deorari AK, Paul VK. Correlation between umbilical cord and maternal intrapartum serum retinol in very low birth weight neonates. Indian J Pharmacol. 2008;40(Suppl 2):S37–56.Google Scholar
  28. 28.
    Georgieff MK, Chockalingam UM, Sasanow SR, Gunter EW, Murphy E, Ophoven JJ. The effect of antenatal betamethasone on cord blood concentrations of retinol-binding protein, transthyretin, transferrin, retinol, and vitamin E. J Pediatr Gastroenterol Nutr. 1988;7:713–7.CrossRefGoogle Scholar
  29. 29.
    Weinman AR, Jorge SM, Martins AR, de Assis Md, Martinez FE, Camelo JS Jr. Assessment of vitamin A nutritional status in newborn preterm infants. Nutrition. 2007;23:454–60.CrossRefGoogle Scholar
  30. 30.
    Jain MK, Mehta NJ, Fonseca M, Pai NV. Correlation of serum vitamin A and its transport protein (RBP) in malnourished and vitamin A deficient children. J Postgrad Med. 1990;36:119–23.PubMedGoogle Scholar

Copyright information

© Association of Clinical Biochemists of India 2019

Authors and Affiliations

  • S. Giridhar
    • 1
  • Jogender Kumar
    • 1
  • Savita Verma Attri
    • 1
  • Sourabh Dutta
    • 1
  • Praveen Kumar
    • 1
    Email author
  1. 1.Division of Neonatology, Department of PediatricsPostgraduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations